LB PHARMACEUTICALS INC — Form D/A
LB PHARMACEUTICALS INC of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2024-01-10. The offering totals $110.7M, of which $110.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-01-10
- Form: D/A
- Accession: 0001691082-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $110.7M
- Amount sold: $110.7M
- Investors: 6
- Date of first sale: 2023-08-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-492682
Issuer
- Name: LB PHARMACEUTICALS INC
- CIK: 0001691082
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 575 MADISON AVENUE, NEW YORK, NY, 10022
- Phone: 212-605-0230
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Rajul Jain | Director | South San Francisco, CA |
| Rebecca Luse | Director | Boston, MA |
| Ran Nussbaum | Director | New York, NY |
| Zachary Prensky | Director | New York, NY |
| Robert Ruffolo | Director | Boston, MA |
| CHEN YU | Director | PALO ALTO, CA |
| Anna Eramo | Executive Officer | New York, NY |
| Marc Panoff | Executive Officer | New York, NY |
| Zachary Prensky | Executive Officer | New York, NY |
| Andrew Vaino | Executive Officer | New York, NY |
| Simon Basseyn | Director | New York, NY |
| Edmund Sullivan | Director | New York, NY |
| Vincent Grattan | Director | New York, NY |
| Piero Poli | Director | New York, NY |
| Mark Panoff | Executive Officer | New York, NY |
| Lauren Stipp | Executive Officer | New York, NY |
Other filings by this issuer (10)
More